Adaptimmune Therapeutics plc (ADAP) dropped -5.17% or -0.64 to $11.74. It is close to 546683 shares traded, which is 128.89% compare to the average total volume 424141. The market cap of ADAP is $1.11 billion. The year to date change is 69.2%. The 52 week price range is from $4.28 to $14.62. Price of ADAP have changed 0.81% during last week. It have changed 1.89% over last month, 11.93% over last 3 months, 72.66% over last 6 months and 172.09% over one year.
Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for ADAP is 12.63. It is 7.58% above current price. The 200-day Moving Averages for ADAP is 9.37. It is -20.19% below current price. The 52-week High is 14.62. It is 24.53% from the current price. The 52-week Low is 4.28. It is -63.54% from current price.
Some people may be interesting about short interest ratio of a stock. The short interest ratio of ADAP is 3.42 on 2018-05-31. Short % to float is 2.11%. There are some statistics of ADAP. It is has market cap $1.11 billion. The share outstanding is 94.14 million. The average volume is 424141. The revenue is 30.71M. The percent of top 15 Institution holding is 89.10%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of ADAP is -32.12%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of ADAP is -25.03%.